Efficacy and Safety of DWP450 for the Treatment of Crows Feet Lines

Phase 3UnknownNCT02882893

Daewoong Pharmaceutical Co. LTD.238 enrolled

Overview

The purpose of this study is to evaluate the Efficacy and Safety of DWP450 treatment of Crows Feet Lines(CFL).

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

DOUBLE

Enrollment

238

Conditions

Crows Feet Lines

Interventions

Clostridium Botulinum A ToxinDRUG

Eligibility

Sex: ALLMin age: 18 YearsMax age: 75 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Male or female of at least 18 to 75 years old * Bilaterally symmetrical moderate-to-severe CFL at maximum smile on the FWS as rated by the investigator

Locations (1)

Konkuk University Medical Center

Seoul, South Korea

RECRUITING

Outcomes

Primary Outcomes

Facial Wrinkle Scale(FWS) severity of Crow's feet lines(CFL) at maximum smile as assessed by investigators

Time frame: At 4 weeks

Central Contacts

Daewoong Clinical

CONTACT

8225508800

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.